WO2003068790A3 - Macrolide antibacterial compounds - Google Patents

Macrolide antibacterial compounds Download PDF

Info

Publication number
WO2003068790A3
WO2003068790A3 PCT/US2003/004117 US0304117W WO03068790A3 WO 2003068790 A3 WO2003068790 A3 WO 2003068790A3 US 0304117 W US0304117 W US 0304117W WO 03068790 A3 WO03068790 A3 WO 03068790A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
antibacterial compounds
macrolide antibacterial
prodrugs
salts
Prior art date
Application number
PCT/US2003/004117
Other languages
French (fr)
Other versions
WO2003068790A2 (en
Inventor
Zhenkun Ma
Richard Clark
Stevan Djuric
Sanyi Wang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/075,011 external-priority patent/US20030171308A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Priority to MXPA04007883A priority Critical patent/MXPA04007883A/en
Priority to JP2003567916A priority patent/JP2005522453A/en
Priority to EP03707854A priority patent/EP1474431A2/en
Priority to CA002476223A priority patent/CA2476223A1/en
Publication of WO2003068790A2 publication Critical patent/WO2003068790A2/en
Publication of WO2003068790A3 publication Critical patent/WO2003068790A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Antibacterial compounds having formula (I), and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods for prophylaxis or treatment of bacterial infections using the compounds are disclosed.
PCT/US2003/004117 2002-02-13 2003-02-11 Macrolide antibacterial compounds WO2003068790A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MXPA04007883A MXPA04007883A (en) 2002-02-13 2003-02-11 Macrolide antibacterial compounds.
JP2003567916A JP2005522453A (en) 2002-02-13 2003-02-11 Macrolide antibacterial compounds
EP03707854A EP1474431A2 (en) 2002-02-13 2003-02-11 Macrolide antibacterial compounds
CA002476223A CA2476223A1 (en) 2002-02-13 2003-02-11 Macrolide antibacterial compounds

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/075,011 2002-02-13
US10/075,011 US20030171308A1 (en) 2002-02-13 2002-02-13 Macrolide antibacterial compounds
US36165103A 2003-02-10 2003-02-10
US10/361,651 2003-02-10

Publications (2)

Publication Number Publication Date
WO2003068790A2 WO2003068790A2 (en) 2003-08-21
WO2003068790A3 true WO2003068790A3 (en) 2003-12-04

Family

ID=27736825

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/004117 WO2003068790A2 (en) 2002-02-13 2003-02-11 Macrolide antibacterial compounds

Country Status (5)

Country Link
EP (1) EP1474431A2 (en)
JP (1) JP2005522453A (en)
CA (1) CA2476223A1 (en)
MX (1) MXPA04007883A (en)
WO (1) WO2003068790A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201509006D0 (en) * 2015-05-26 2015-07-08 Redx Pharma Plc Antibacterial compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998009978A1 (en) * 1996-09-04 1998-03-12 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
CO4990960A1 (en) * 1997-10-29 2000-12-26 Abbott Lab 2-HALO-6-O SUBSTITUTED CETOLIDE DERIVATIVES

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity

Also Published As

Publication number Publication date
MXPA04007883A (en) 2004-11-26
CA2476223A1 (en) 2003-08-21
WO2003068790A2 (en) 2003-08-21
JP2005522453A (en) 2005-07-28
EP1474431A2 (en) 2004-11-10

Similar Documents

Publication Publication Date Title
WO2006120563A3 (en) Antibacterial agents
HUP0400446A2 (en) Crystal forms of azithromycin
MXPA05008126A (en) Gyrase inhibitors and uses thereof.
WO2002007742A8 (en) Bacteriophage having multiple host range
MXPA03003168A (en) Topical antibiotic composition for treatment of eye infection.
TW200734344A (en) Antibacterial agents
GB0125222D0 (en) Composition for the treatment of microbial infections
EP1594444A3 (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
WO2004062601A3 (en) Antibacterial agents
WO2003010138A3 (en) Piperidine derivatives as antibacterial agents
WO2007067559A3 (en) Antibacterial agents
AU3196900A (en) Preventives/remedies for interstitial pneumonia and pulmonary fibrosis
ZA200507070B (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
WO2004080391A3 (en) Novel antibacterial agents
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
AU2003298662A1 (en) Dalbavancin compositions for treatment of bacterial infections
AU2003245928A1 (en) Antibacterial amide macrocycles
MXPA05009688A (en) Naphthyridine derivatives as antibacterial agents.
WO2004096822A3 (en) Pyridyl substituted ketolide antibiotics
WO2002064574A3 (en) Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
WO2004043928A3 (en) N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
WO2002032919A3 (en) 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance
WO2004098500A3 (en) CARBACEPHEM ss-LACTAM ANTIBIOTICS
CA2380455A1 (en) 9a-azalides with antibacterial activity
WO2006018807A8 (en) Crystalline forms of cefdinir

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA CN JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003567916

Country of ref document: JP

Ref document number: 2476223

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/007883

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2003707854

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003707854

Country of ref document: EP